Clinical Trial Update: A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study by MedImmune evaluating safety and antitumor activity in adults with advanced solid tumors, including advanced recurrent ovarian tumors. Results w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Solid Tumors

Snippet

Sponsor: MedImmune LLC | Conditions: Advanced Solid Tumors, Advanced Recurrent Ovarian Tumors | Phase 1 | Status: COMPLETED | Results posted: 2017-03-29